FDA Withdraws Approval of 10 Abbreviated New Drug Applications from Tedor Pharma, Inc. and Others

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of 10 abbreviated new drug applications (ANDAs) from multiple pharmaceutical companies, including Tedor Pharma, Inc., following written notifications that the corresponding drug products are no longer commercially available.